Inventor · disambiguated record
Desire Collen
Also filed as: COLLEN DESIRE · COLLEN DESIRE J · COLLEN DESIRE JOSE · COLLEN DESIREJOSE
39 granted patents·21 pending applications·511 citations·filing 1977–2014
98Inventor score
Files withLEUVEN RES & DEV VZW22VLAAMS INTERUNIV INST BIOTECH8CARMELIET PETER5D COLLEN RES FOUNDATION VZW2LUDWIG INST CANCER RES2
Top patents by PatentIndex Score
60 records- 0196US6309888B1Detection and determination of the stages of coronary artery diseaseLEUVEN RES & DEV VZW·Filed 1998·Granted Oct 30, 2001·124 cites·54 claims
- 0287US7875704B2Anti-PLGF antibodyVLAAMS INTERUNIV INST BIOTECH·Filed 2006·Granted Jan 25, 2011·8 cites·17 claims
- 0385US7390627B2Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteinsLEUVEN RES & DEV VZW·Filed 2007·Granted Jun 24, 2008·6 cites·19 claims
- 0483US7357929B2Placental growth factor as a target for the treatment of osteoporosisD COLLEN RES FOUNDATION VZW·Filed 2003·Granted Apr 15, 2008·27 cites·1 claims
- 0583US7105168B1Method of improving ischemic muscle function by administering placental growth factorD COLLEN RES FOUNDATION VZW·Filed 2003·Granted Sep 12, 2006·14 cites·6 claims
- 0682US4198335AAntiplasmin and antiserumLEUVEN RES & DEV VZW·Filed 1977·Granted Apr 15, 1980·15 cites·8 claims
- 0781US7482004B2Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2002·Granted Jan 27, 2009·13 cites·9 claims
- 0881US7229776B2Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteinsLEUVEN RES & DEV VZW·Filed 2004·Granted Jun 12, 2007·11 cites·2 claims
- 0980US7579159B2Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteinsLEUVEN RES & DEV VZW·Filed 2007·Granted Aug 25, 2009·4 cites·8 claims
- 1079US7592314B2Use of VEGF and homologues to treat neuron disordersVIAAMS INTERUNIVERSITAIR INST·Filed 2007·Granted Sep 22, 2009·5 cites·4 claims
- 1179US7378250B2Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteinsLEUVEN RES & DEV VZW·Filed 2007·Granted May 27, 2008·3 cites·2 claims
- 1279US6727102B1Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteinsLEUVEN RES & DEV VZW·Filed 1997·Granted Apr 27, 2004·34 cites·19 claims
- 1378US7166469B2Detection and determination of the stages of coronary artery diseaseLEUVEN RES & DEV VZW·Filed 2002·Granted Jan 23, 2007·12 cites·32 claims
- 1477US7226908B2Use of VEGF and homologues to treat neuron disordersCOLLEN RES FOUNDATION VZW·Filed 2001·Granted Jun 5, 2007·14 cites·16 claims
- 1576US7229775B2Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteinsLEUVEN RES & DEV VZW·Filed 2004·Granted Jun 12, 2007·8 cites·10 claims
- 1675US7604952B2Detection and determination of the stages of coronary artery diseaseLEUVEN RES & DEV VZW·Filed 2007·Granted Oct 20, 2009·3 cites·17 claims
- 1773US8758748B2Anti-angiogenic therapySTASSEN JEAN-MARIE·Filed 2010·Granted Jun 24, 2014·3 cites·6 claims
- 1873US4623718ANovel composition of matter of antithrombin III bound to a heparin fragmentKABIVITRUM AB·Filed 1983·Granted Nov 18, 1986·12 cites·4 claims
- 1972US7709450B2Stimulation of vascularization with VEGF-B-186LUDWIG INST CANCER RES·Filed 2002·Granted May 4, 2010·6 cites·11 claims
- 2071US7341992B2Lectin-like domain of thrombomodulin and its therapeutic useVLAAMS INTERUNIV INST BIOTECH·Filed 2002·Granted Mar 11, 2008·5 cites·9 claims
- 2170US6902733B2Staphylokinase derivatives with polyethyleneglycolLEUVEN RES & DEV VZW·Filed 2000·Granted Jun 7, 2005·1 cites·7 claims
- 2270US5951980AIdentification, production and use of new staphylokinase derivatives with reduced immunogenicityLEUVEN RES & DEV VZW·Filed 1997·Granted Sep 14, 1999·32 cites·12 claims
- 2369US7888322B2Use of VEGF and homologues to treat neuron disordersVLAAMS INTERUNIV INST BIOTECH·Filed 2008·Granted Feb 15, 2011·0 cites·5 claims
- 2468US7445775B2Yeast expression vector and a method of making a recombinant protein by expression in a yeast cellTHROMB X NV·Filed 2001·Granted Nov 4, 2008·6 cites·32 claims
- 2565US6946438B1Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic strokeLEUVEN RES & DEV VZW·Filed 1999·Granted Sep 20, 2005·20 cites·1 claims
- 2665US2009238826A1Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2009·Application pending·0 cites
- 2764US6398757B1Gene therapeutic treatment of blood vessel associated disordersLEUVEN RES & DEV VZW·Filed 1998·Granted Jun 4, 2002·31 cites·6 claims
- 2864US2009074765A1Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2008·Application pending·0 cites
- 2964US2009162354A1Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2008·Application pending·0 cites
- 3063US7727971B2Use of placental growth factor for treating ischemic muscle diseaseLIFE SCIENCES RES PARTNERS VZW·Filed 2006·Granted Jun 1, 2010·0 cites·12 claims
- 3162US6383483B1Staphylokinase derivatives with cysteine substitutionsFiled 1998·Granted May 7, 2002·10 cites·5 claims
- 3262US2008032314A1Use of VEGF and homologuest to treat neuron disordersCAMELIET PETER·Filed 2007·Application pending·0 cites
- 3360US9085617B2Anti-angiogenic therapyVLAAMS INTERUNIV INST BIOTECH·Filed 2014·Granted Jul 21, 2015·0 cites·22 claims
- 3459US4752603APlasminogen activator and pharmaceutical composition having thrombolytic activityLEUVEN RES & DEV VZW·Filed 1986·Granted Jun 21, 1988·29 cites·3 claims
- 3557US2005136045A1Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearanceCOLLEN DESIRE JOSE·Filed 2004·Application pending·0 cites
- 3657US2004127449A1Method of inducing vasodilation and treating pulmonary hypertension using adenoviral -mediated transfer of the nitric oxide synthase geneFiled 2003·Application pending·0 cites
- 3756US4202872ADetermination of heparin in blood plasmaLEUVEN RES & DEV VZW·Filed 1977·Granted May 13, 1980·12 cites·6 claims
- 3855US2013177565A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2013·Application pending·0 cites
- 3955US2013183310A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2013·Application pending·0 cites
- 4055US2013177564A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2013·Application pending·0 cites
- 4154US2007172423A1Composition and method for modulating vasculogenesis for angiogenesisLI XURI·Filed 2006·Application pending·0 cites
- 4254US2012263710A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2012·Application pending·0 cites
- 4351US2005186204A1Use of antibodies against FLT-1 for the treatment of osteoporosisFiled 2004·Application pending·0 cites
- 4450US4346029AAntiplasmin and antiserumLEUVEN RES & DEV VZW·Filed 1979·Granted Aug 24, 1982·8 cites·3 claims
- 4550US4216291AThrombosis-testLEUVEN RES & DEV VZW·Filed 1978·Granted Aug 5, 1980·10 cites·8 claims
- 4650US2003211994A1Composition and method for modulating vasculogenesis or angiogenesisLUDWIG INST CANCER RES·Filed 2002·Application pending·0 cites
- 4750US2011288020A1Use of VEGF and homologues to treat neuron disordersCARMELIET PETER·Filed 2010·Application pending·0 cites
- 4850US2006183671A1Treatment of anemiaANGELILLO-SCHERRER ANNE·Filed 2004·Application pending·0 cites
- 4946US5275812AMethod of treatment for myocardial infarctionGEN HOSPITAL CORP·Filed 1993·Granted Jan 4, 1994·12 cites·11 claims
- 5045US2003134335A1Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopesFiled 2000·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Desire Collen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →